Page last updated: 2024-08-24

technetium tc 99m mertiatide and Cancer of Prostate

technetium tc 99m mertiatide has been researched along with Cancer of Prostate in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blok, D; Drijfhout, JW; Feitsma, HI; Kooy, YM; Ossendorp, F; Vermeij, P; Welling, MM1

Other Studies

1 other study(ies) available for technetium tc 99m mertiatide and Cancer of Prostate

ArticleYear
New chelation strategy allows for quick and clean 99mTc-labeling of synthetic peptides.
    Nuclear medicine and biology, 2004, Volume: 31, Issue:6

    Topics: Binding, Competitive; Bombesin; Cell Line, Tumor; Chelating Agents; Drug Stability; Humans; Isotope Labeling; Male; Peptides; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Bombesin; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Technetium; Technetium Tc 99m Mertiatide

2004